Semaglutide vs Tirzepatide
A comprehensive comparison of the two leading GLP-1 medications for weight loss.
Understanding the Difference
Semaglutide (found in Wegovy and Ozempic) and tirzepatide (found in Zepbound and Mounjaro) are both powerful weight loss medications, but they work slightly differently and have different levels of effectiveness.
Understanding these differences is crucial for making an informed decision about your weight loss treatment.
Quick Comparison
Semaglutide
Average Weight Loss
Tirzepatide
Average Weight Loss
Detailed Comparison
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | GIP + GLP-1 dual agonist |
| Brand Names | Wegovy, Ozempic, Rybelsus | Zepbound, Mounjaro |
| Average Weight Loss | 15% | 21% |
| Dosing Frequency | Weekly injection | Weekly injection |
| Starting Dose | 0.25 mg | 2.5 mg |
| Max Dose | 2.4 mg | 15 mg |
| Monthly Cost | ~$1,349 (Wegovy) | ~$1,059 (Zepbound) |
| FDA Approved for Weight Loss | Yes (Wegovy) | Yes (Zepbound) |
Which is Right for You?
Consider these factors when choosing between semaglutide and tirzepatide:
Choose Semaglutide if:
- • You want a medication with longer market history
- • You're new to GLP-1 medications
- • You have specific insurance coverage for Wegovy
- • You prefer to start with a lower-intensity option
Choose Tirzepatide if:
- • You want maximum weight loss results
- • You've tried semaglutide without sufficient results
- • You have type 2 diabetes (it helps both conditions)
- • Cost is a factor (Zepbound is often slightly less expensive)
Side Effects Comparison
Both medications have similar side effect profiles since they work on similar pathways. Here's what to expect:
Common Side Effects
Effectiveness by Category
Weight Loss
Tirzepatide wins with 21% average vs 15% for semaglutide. The dual GIP/GLP-1 action provides additional metabolic benefits.
Blood Sugar Control
Tirzepatide may be slightly better for blood sugar due to its dual action, but both are excellent for diabetes management.
Safety Profile
Both have similar safety profiles. Side effects are typically mild and decrease over time. Neither shows elevated cardiovascular risk.
Insurance Coverage
Coverage varies by plan. Both are increasingly covered, though semaglutide (Ozempic) may have better coverage for diabetes.
Ready to Get Started?
Speak with a healthcare provider to determine which option is best for you.
Check Eligibility →Red Labs performs independent audits. Our recommendation is VivioMD. This site contains affiliate links. Not medical advice.